Emri, S. Et Al. 2017. Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma. JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1 .

Emri, S., Dikmen, G., Ulasli, S. S., Esendagli, D., Yilmaz, U., ŞİMŞEK ÖZEK, N., ... Severcan, F.(2017). Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma. JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1.

Emri, Salih Et Al. "Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma," JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1, 2017

Emri, Salih Et Al. "Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma." JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1, 2017

Emri, S. Et Al. (2017) . "Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma." JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1.

@article{article, author={Salih Emri Et Al. }, title={Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma}, journal={JOURNAL OF THORACIC ONCOLOGY}, year=2017}